Study Information

Title: Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer External
Status: Recruiting participants
Conditions: Esophageal Cancer
Interventions: Biological: cetuximab; Drug: cisplatin; Drug: epirubicin hydrochloride; Drug: fluorouracil; Drug: irinotecan hydrochloride; Drug: leucovorin calcium; Drug: oxaliplatin
Institutions: Brigham and Women's Hospital, Dana-Farber Cancer Institute, Massachusetts General Hospital, Baystate Medical Center, Lahey Clinic Medical Center
Health Topics: Esophageal Cancer, Head and Neck Cancer
View this study on ClinicalTrials.gov

Contact Information

Baystate Regional Cancer Program at D'Amour Center for Cancer Care
Springfield, MA 01199
John McCann, MD
413-794-3316
Dana-Farber/Brigham and Women's Cancer Center
Boston, MA 02115
Clinical Trials Office
617-724-5200
Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute
Boston, MA 02115
Peter C. Enzinger
617-632-3474
Lahey Clinic Medical Center - Burlington
Burlington, MA 01805
Clinical Trials Office - Lahey Clinic Medical Center - Burling
781-744-8027
Massachusetts General Hospital
Boston, MA 02114
Clinical Trials Office - Massachusetts General Hospital
877-726-5130
South Shore Hospital
South Weymouth, MA 02190
Peter C. Enzinger
781-340-8000